Industry Blog

Flight ban stops pharmaceutical produce.

It is said today that Pharmaceutical companies could be the worst off over this flight business, as production of pills are not being transferred to where they need to be.

Christopher Snelling, FTA’s head of global supply said: ‘Consumers won’t notice too much difference on consumer goods but it may be a problem for processes in the manufacturing industry.’

‘Flying in components could be a problem for particular factories. And I think they may have happened already in the pharmaceuticals industry.’

It’s estimated that 25 – 30% of exports into Britain are by plane, and the Pharmaceutical companies need their produce as soon as possible. If flights take so long to arrive then many medicines that go by shelf life could expire and become unusable.

Are you getting the medicine you should be?

Would you ever notice if you were given ‘cheap’ medicine instead of the one you actually thought you were getting?

Well it does happen, some chemists will give you ‘cheaper made’ tablets instead of the ones that are more expensive to make.

One lady inparticular had noticed and decided to ask her pharmacist why.

Susan Robinson explains that she has epilepsy and something started to go wrong. ‘I began to have a lot more fits, as many as two a week instead of one every one or two months.

‘It was really scary - I never knew when it was going to happen,’ she says.

‘I developed epilepsy late - in my early 50s - and am still coming to terms with it.

‘But just when it was starting to become manageable, I was tipped back into the state I’d been in when it all started,’ says Mrs Robinson.

She took a closer look at the packaging of her prescription. ‘It looked different to the others I’d had. It had Portuguese writing and was called Topamac.

‘The pharmacist said he had substituted it for my regular brand-name drug to save money.’

It is done to save money, but what if it makes people’s health deteriorate?

If you think that your prescription is not what you think it should be then contact your pharmacist or speak to someone inside the pharmaceutical industry where you received it from.

Patch up for Mexico.

Pharmaceutical Companies in the United States have approached a new way to get people new medicine for tummy problems when flying to Mexico. It is a common fact that when people travel to this country its likely to get an upset stomache.

Pharmaceutical companies are offering free holidays to 900 volunteers, to eat drink and see if they become ill whilst in Mexico or Guatemala. The holidays on offer are worth $1,000 and are inclusive including 3 star hotels. The travelers can roam where ever they please, just aslong as they are not more than 3 hours away from the test centre, which is where they must provide blood and stool samples if they become sick.

Previously to them flying out to the countries, which can cause stomache upset due to water problems and different things to what people are normally used to in other countries, they have to wear a patch for 6 hours, 3 weeks before. They also have to wear another patch 1 week before they fly out, after this all they have to do is fly out and see what happens.

Results have shown so far that the drug has actually reduced the incident of an upset stomache by 75%, it is only in America at present but will be brought over to UK in the near future.

Pharmaceutical to market blood pressure pill in Canada

Mississauga-based Ranbaxy Pharmaceuticals-Canada Inc. will be manufacturing and marketing Ran-Amlodipine tablets.

The Canadian subsidiary of India’s largest pharmaceutical company, Ranbaxy Laboratories Limited, announced today it received final approval from Health Canada to make and market pills that help high blood pressure and chest pains caused by an insufficient supply of blood to the heart muscle.

Paul Drake, the president of Ranbaxy Pharmaceuticals-Canada Inc. on Matheson Blvd. E., says they’re looking forward to marketing Ran-Amlodipine tablets as an antihypertensive-antianginal pill.

mississauganews.com

Scottish woman is first Briton to die from swine flu

A patient suffering from swine flu has died in hospital in Scotland, becoming the first person outside the Americas to have been killed by the virus.

The Scottish government disclosed that the patient, thought to be from the Paisley area and one of 10 Scots in hospital with the H1N1 virus, had underlying health problems.

Last night the victim was locally identified as a 38-year-old woman from Glasgow, who had prematurely given birth to a baby in recent days. She had been in intensive care at the Royal Alexandra hospital in Paisley, where a large number of those infected with the H1N1 virus have been treated. Health officials said earlier today that nearly 500 people in Scotland had been diagnosed with the virus, with a majority in the Greater Glasgow and Clyde area.

The Scottish government released a statement shortly before 8pm tonight, stating: “With regret, we can confirm that one of the patients who had been in hospital and had been confirmed as suffering from the H1N1 virus, has died today. At the family’s request, to allow them time to come to terms with their loss, no further details will be released tonight.”

Nicola Sturgeon, the Scottish health secretary, said: “I’d like to express my condolences to the patient’s family and friends,” she said. “This is a tragedy for those concerned and they have my heartfelt sympathy. Tragic though today’s death is, I would like to emphasise that the vast majority of those who have H1N1 are suffering from relatively mild symptoms.”

Glaxo to reduce medicine costs to World’s poorest

GlaxoSmithKline will reduce the cost of its medicines and patents to the world’s poor, raising hopes that its rivals will follow suit, according to an article posted recently on Pharmiweb.

In a speech at Harvard Medical School on 13 February, the chairman of GSK, Andrew Witty, declared that his company would “earn its right to exist” by meeting the expectations of society, not just shareholders. He said that GSK would cut the prices of all its medicines in 50 poor countries - to no more than 25 per cent of the price in wealthy nations. The company will also provide free access to its patents relating to neglected diseases - those into which there is a lack of current research.

Oxfam spokesman Rohit Malpani urged other companies to emulate GSK, but would like to see the company free up its anti-HIV medication patents as well. Richard Barker of the Association of the British Pharmaceutical Industry says GSK’s stance will spark a debate about “how much further industry can and should go” in promoting global health.

Tag Cloud